William Gerber, a non-independent member of the Nanogen's board of directors, resigned from the board effective May 1, the company said this week.
 
Nanogen said Gerber’s resignation restores compliance with Nasdaq Marketplace Rule 4350(c)(1), which requires a majority of members of the board of directors to be comprised of independent directors.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.